Off-the-shelf tissue engineered heart valves for in situ regeneration: current state, challenges and future directions

References

• Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012). Eur J Cardiothorac Surg. 2012;42(4):S1–44.
   Google Scholar
• Arora S, Misenheimer JA, Ramaraj R. Transcatheter aortic valve replacement: comprehensive review and present status. Tex Heart Inst J. 2017;44(1):29–38.
   PubMed Web of Science ®Google Scholar
• Kenny DP, Hijazi ZM. Current status and future potential of transcatheter interventions in congenital heart disease. Circ Res. 2017;120(6):1015–1026.
   PubMed Web of Science ®Google Scholar
• Alsara O, Alsarah A, Laird-Fick H. Advanced age and the clinical outcomes of transcatheter aortic valve implantation. J Geriatr Cardiol. 2014;11(2):163–170.
   PubMedGoogle Scholar
• Mack MJ, Leon MB, Smith CR, et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385(9986):2477–2484.
   PubMed Web of Science ®Google Scholar
• Kim SJ, Samad Z, Bloomfield GS, et al. A critical review of hemodynamic changes and left ventricular remodeling after surgical aortic valve replacement and percutaneous aortic valve replacement. Am Heart J. 2014;168(2):150–159.e151–157.
   Web of Science ®Google Scholar
• Yoon S-H, Schmidt T, Bleiziffer S, et al. Transcatheter aortic valve replacement in pure native aortic valve regurgitation. J Am Coll Cardiol. 2017;70(22):2752–2763.
   PubMed Web of Science ®Google Scholar
• Dasi LP, Simon HA, Sucosky P, et al. Fluid mechanics of artificial heart valves. Clin Exp Pharmacol Physiol. 2009;36(2):225–237.
   PubMed Web of Science ®Google Scholar
• Leopold JA. Cellular mechanisms of aortic valve calcification. Circ Cardiovasc Interv. 2012;5(4):605–614.
   PubMed Web of Science ®Google Scholar
• Manji RA, Lee W, Cooper DK. Xenograft bioprosthetic heart valves: past, present and future. Int J Surg. 2015;23(Pt B):280–284.
   PubMedGoogle Scholar
• Siddiqui RF, Abraham JR, Butany J. Bioprosthetic heart valves: modes of failurel. Histopathology. 2009;55(2):135–144.
   Google Scholar
• Petronio AS, Capranzano P, Barbato E, et al. Current status of transcatheter valve therapy in Europe: results from an EAPCI survey. Euro Interv. 2016;12(7):890–895.
   Google Scholar
• Bezuidenhout D, Williams DF, Zilla P. Polymeric heart valves for surgical implantation, catheter-based technologies and heart assist devices. Biomaterials. 2015;36:6–25.
   PubMed Web of Science ®Google Scholar
• Sachweh JS, Daebritz SH. Novel “biomechanical” polymeric valve prostheses with special design for aortic and mitral position: a future option for pediatric patients? ASAIO J. 2006;52(5):575–580.
   PubMed Web of Science ®Google Scholar
• Ando M, Takahashi Y. Ten-year experience with handmade trileaflet polytetrafluoroethylene valved conduit used for pulmonary reconstruction. J Thorac Cardiovasc Surg. 2009;137(1):124–131.
   PubMed Web of Science ®Google Scholar
• Daebritz SH, Fausten B, Hermanns B, et al. New flexible polymeric heart valve prostheses for the mitral and aortic positions. Heart Surg Forum. 2004;7(5):E525–532.
   PubMed Web of Science ®Google Scholar
• Leo HL, Simon H, Carberry J, et al. A comparison of flow field structures of two tri-leaflet polymeric heart valves. Ann Biomed Eng. 2005;33(4):429–443.
   PubMed Web of Science ®Google Scholar
• Wheatley DJ, Raco L, Bernacca GM, et al. Polyurethane: material for the next generation of heart valve prostheses? Eur J Cardiothorac Surg. 2000;17(4):440–448.
   PubMed Web of Science ®Google Scholar
• Wang Q, McGoron AJ, Bianco R, et al. In-vivo assessment of a novel polymer (SIBS) trileaflet heart valve. J Heart Valve Dis. 2010;19(4):499–505.
   PubMed Web of Science ®Google Scholar
• Claiborne TE, Sheriff J, Kuetting M, et al. In vitro evaluation of a novel hemodynamically optimized trileaflet polymeric prosthetic heart valve. J Biomech Eng. 2013;135(2):021021.
   PubMed Web of Science ®Google Scholar
• Chester AH, El-Hamamsy I, Butcher JT, et al. The living aortic valve: from molecules to function. Global Cardiol Sci Practice. 2014;2014(1):52–77.
   PubMedGoogle Scholar
• Balachandran K, Sucosky P, Yoganathan AP. Hemodynamics and mechanobiology of aortic valve inflammation and calcification. Int J Inflam. 2011;2011:1–15.
   Google Scholar
• Ayoub S, Ferrari G, Gorman RC, et al. Heart valve biomechanics and underlying mechanobiology. Compr Physiol. 2016;6(4):1743–1780.
   PubMed Web of Science ®Google Scholar
• Fioretta ES, Dijkman PE, Emmert MY, et al. The future of heart valve replacement: recent developments and translational challenges for heart valve tissue engineering. J Tissue Eng Regen Med. 2017. [Epub ahead of print].
   Google Scholar
• Langer R, Vacanti JP. Tissue engineering. Science. 1993;260(5110):920–926.
   PubMed Web of Science ®Google Scholar
• Wissing TB, Bonito V, Bouten CVC, et al. Biomaterial-driven in situ cardiovascular tissue engineering—a multi-disciplinary perspective. NPJ Regen Med. 2017;2(1):18.
   Google Scholar
• Dijkman PE, Fioretta ES, Frese L, et al. Heart valve replacements with regenerative capacity. Transfus Med Hemotherapy. 2016;43(4):282–290.
   PubMed Web of Science ®Google Scholar
• Loon S, Smits AIPM, Driessen-Mol A, et al. The immune response in in situ tissue engineering of aortic heart valves. In: Aikawa E, editor. Calcific aortic valve disease. Rijeka: InTech; 2013. Chapter 08.
   Google Scholar
• Williams DF. To engineer is to create: the link between engineering and regeneration. Trends Biotechnol. 2006;24(1):4–8.
   PubMed Web of Science ®Google Scholar
• Cheung DY, Duan B, Butcher JT. Current progress in tissue engineering of heart valves: multiscale problems, multiscale solutions. Expert Opin Biol Ther. 2015;15(8):1155–1172.
   PubMed Web of Science ®Google Scholar
• Kluin J, Talacua H, Smits AI, et al. In situ heart valve tissue engineering using a bioresorbable elastomeric implant - from material design to 12 months follow-up in sheep. Biomaterials. 2017;125:101–117.
   PubMed Web of Science ®Google Scholar
• Schmidt D, Achermann J, Odermatt B, et al. Prenatally fabricated autologous human living heart valves based on amniotic fluid–derived progenitor cells as single cell source. Circulation. 2007;116(11suppl):I-64-I-70.
   PubMedGoogle Scholar
• Jana S, Tefft BJ, Spoon DB, et al. Scaffolds for tissue engineering of cardiac valves. Acta Biomater. 2014;10(7):2877–2893.
   PubMed Web of Science ®Google Scholar
• Hopkins R. From cadaver harvested homograft valves to tissue-engineered valve conduits. Prog Pediatr Cardiol. 2006;21(2):137–152.
   Google Scholar
• Antoine EE, Vlachos PP, Rylander MN. Review of collagen I hydrogels for bioengineered tissue microenvironments: characterization of mechanics, structure, and transport. Tissue Eng Part B Rev. 2014;20(6):683–696.
   PubMed Web of Science ®Google Scholar
• Li Y, Meng H, Liu Y, et al. Fibrin gel as an injectable biodegradable scaffold and cell carrier for tissue engineering. ScientificWorldJournal. 2015;685690:2015.
   Google Scholar
• Burdick JA, Prestwich GD. Hyaluronic acid hydrogels for biomedical applications. Adv Mater. 2011;23(12):H41–H56.
   PubMed Web of Science ®Google Scholar
• Duan J, Liang X, Cao Y, et al. High strength chitosan hydrogels with biocompatibility via new avenue based on constructing nanofibrous architecture. Macromolecules. 2015;48(8):2706–2714.
   Web of Science ®Google Scholar
• Koshy ST, Desai RM, Joly P, et al. Click-crosslinked injectable gelatin hydrogels. Adv Healthc Mater. 2016;5(5):541–547.
   PubMed Web of Science ®Google Scholar
• Ye Q, Zund G, Benedikt P, et al. Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. Eur J Cardiothorac Surg. 2000;17(5):587–591.
   PubMed Web of Science ®Google Scholar
• Flanagan TC, Cornelissen C, Koch S, et al. The in vitro development of autologous fibrin-based tissue-engineered heart valves through optimised dynamic conditioning. Biomaterials. 2007;28(23):3388–3397.
   PubMed Web of Science ®Google Scholar
• Kim WG, Cho SK, Kang MC, et al. Tissue-engineered heart valve leaflets: an animal study. Int J Artif Organs. 2001;24(9):642–648.
   PubMed Web of Science ®Google Scholar
• Sodian R, Hoerstrup SP, Sperling JS, et al. Early in vivo experience with tissue-engineered trileaflet heart valves. Circulation. 2000;102(19Suppl 3):Iii22–29.
   PubMedGoogle Scholar
• Serruys PW, Miyazaki Y, Katsikis A, et al. Restorative valve therapy by endogenous tissue restoration: tomorrow’s world? Reflection on the EuroPCR 2017 session on endogenous tissue restoration. Euro Interv. 2017;13(AA):AA68–AA77.
   Google Scholar
• Bockeria LA, Svanidze O, Kim A, et al. Total cavopulmonary connection with a new bioabsorbable vascular graft: first clinical experience. J Thorac Cardiovasc Surg. 2017;153(6):1542–1550.
   PubMed Web of Science ®Google Scholar
• Miyazaki Y, Soliman O, Abdelghani M, et al. Acute performance of a novel restorative transcatheter aortic valve: preclinical results. Eurointervention. 2017;13(12):e1410–1417.
   Google Scholar
• Eslami M, Vrana NE, Zorlutuna P, et al. Fiber-reinforced hydrogel scaffolds for heart valve tissue engineering. J Biomater Appl. 2014;29(3):399–410.
   PubMed Web of Science ®Google Scholar
• Capulli AK, Emmert MY, Pasqualini FS, et al. JetValve: rapid manufacturing of biohybrid scaffolds for biomimetic heart valve replacement. Biomaterials. 2017;133:229–241.
   PubMed Web of Science ®Google Scholar
• Hockaday LA, Kang KH, Colangelo NW, et al. Rapid 3D printing of anatomically accurate and mechanically heterogeneous aortic valve hydrogel scaffolds. Biofabrication. 2012;4(3):035005.
   PubMed Web of Science ®Google Scholar
• Dhandayuthapani B, Yoshida Y, Maekawa T, et al. Polymeric scaffolds in tissue engineering application: a review. Int J Polym Sci. 2011;2011.
   PubMed Web of Science ®Google Scholar
• Hinderer S, Seifert J, Votteler M, et al. Engineering of a bio-functionalized hybrid off-the-shelf heart valve. Biomaterials. 2014;35(7):2130–2139.
   PubMed Web of Science ®Google Scholar
• Iop L, Gerosa G. Guided tissue regeneration in heart valve replacement: from preclinical research to first-in-human trials. Biomed Res Int. 2015;432901:2015.
   Google Scholar
• Hoshiba T, Lu H, Kawazoe N, et al. Decellularized matrices for tissue engineering. Expert Opin Biol Ther. 2010;10(12):1717–1728.
   PubMed Web of Science ®Google Scholar
• Neumann A, Cebotari S, Tudorache I, et al. Heart valve engineering: decellularized allograft matrices in clinical practice. Biomed Tech (Berl). 2013;58(5):453–456.
   PubMed Web of Science ®Google Scholar
• Lisy M, Kalender G, Schenke-Layland K, et al. Allograft heart valves: current aspects and future applications. Biopreserv Biobank. 2017;15(2):148–157.
   PubMed Web of Science ®Google Scholar
• Lichtenberg A, Cebotari S, Tudorache I, et al. Flow-dependent re-endothelialization of tissue-engineered heart valves. J Heart Valve Dis. 2006;15(2):287–293; discussion 293–284.
   PubMed Web of Science ®Google Scholar
• Neumann A, Sarikouch S, Breymann T, et al. Early systemic cellular immune response in children and young adults receiving decellularized fresh allografts for pulmonary valve replacement. Tissue Eng Part A. 2014;20(5–6):1003–1011.
   PubMed Web of Science ®Google Scholar
• Sarikouch S, Horke A, Tudorache I, et al. Decellularized fresh homografts for pulmonary valve replacement: a decade of clinical experience. Eur J Cardiothorac Surg. 2016;50(2):281–290.
   PubMed Web of Science ®Google Scholar
• Tudorache I, Horke A, Cebotari S, et al. Decellularized aortic homografts for aortic valve and aorta ascendens replacement. Eur J Cardiothorac Surg. 2016;50(1):89–97.
   PubMed Web of Science ®Google Scholar
• Sarikouch S, Haverich A, Pepper J, et al. Every like is not the same. J Thorac Cardiovasc Surg. 2017;153(6):1553–1555.
   PubMed Web of Science ®Google Scholar
• Helder MRK, Kouchoukos NT, Zehr K, et al. Late durability of decellularized allografts for aortic valve replacement: A word of caution. J Thorac Cardiovasc Surg. 2016;152(4):1197–1199.
   PubMed Web of Science ®Google Scholar
• Bloch O, Erdbrugger W, Volker W, et al. Extracellular matrix in deoxycholic acid decellularized aortic heart valves. Medl Sci Monit. 2012;18(12):Br487–492.
   PubMed Web of Science ®Google Scholar
• Hennessy RS, Go JL, Hennessy RR, et al. Recellularization of a novel off-the-shelf valve following xenogenic implantation into the right ventricular outflow tract. PloS One. 2017;12(8):e0181614.
   PubMed Web of Science ®Google Scholar
• Gallo M, Bonetti A, Poser H, et al. Decellularized aortic conduits: could their cryopreservation affect post-implantation outcomes? A morpho-functional study on porcine homografts. Heart Vessels. 2016;31(11):1862–1873.
   PubMed Web of Science ®Google Scholar
• Dohmen PM. Tissue engineered aortic valve. HSR Proc Intensive Care Cardiovasc Anesth. 2012;4(2):89–93.
   PubMedGoogle Scholar
• Simon P, Kasimir MT, Seebacher G, et al. Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J Cardiothorac Surg. 2003;23(6):1002–1006; discussion 1006.
   PubMed Web of Science ®Google Scholar
• Namiri M, Ashtiani MK, Mashinchian O, et al. Engineering natural heart valves: possibilities and challenges. J Tissue Eng Regen Med. 2017;11(5):1675–1683.
   PubMed Web of Science ®Google Scholar
• Hoerstrup SP, Sodian R, Daebritz S, et al. Functional living trileaflet heart valves grown in vitro. Circulation. 2000;102(19Suppl 3):Iii44–49.
   PubMedGoogle Scholar
• Hoerstrup SP, Kadner A, Melnitchouk S, et al. Tissue engineering of functional trileaflet heart valves from human marrow stromal cells. Circulation. 2002;106(12 Suppl 1):1143–1150.
   Google Scholar
• Syedain ZH, Bradee AR, Kren S, et al. Decellularized tissue-engineered heart valve leaflets with recellularization potential. Tissue Eng Part A. 2013;19(5–6):759–769.
   PubMed Web of Science ®Google Scholar
• Fahrenholtz M, Liu H, Kearney D, et al. Characterization of dermal fibroblasts as a cell source for pediatric tissue engineered heart valves. J Cardiovasc Dev Dis. 2014;1(2):146–162.
   Google Scholar
• Syedain Z, Reimer J, Schmidt J, et al. 6-month aortic valve implantation of an off-the-shelf tissue-engineered valve in sheep. Biomaterials. 2015;73:175–184.
   PubMed Web of Science ®Google Scholar
• Schmidt D, Dijkman PE, Driessen-Mol A, et al. Minimally-invasive implantation of living tissue engineered heart valves: a comprehensive approach from autologous vascular cells to stem cells. J Am Coll Cardiol. 2010;56(6):510–520.
   PubMed Web of Science ®Google Scholar
• Dijkman PE, Driessen-Mol A, De Heer LM, et al. Trans-apical versus surgical implantation of autologous ovine tissue-engineered heart valves. J Heart Valve Dis. 2012;21(5):670–678.
   PubMed Web of Science ®Google Scholar
• Dijkman PE, Driessen-Mol A, Frese L, et al. Decellularized homologous tissue-engineered heart valves as off-the-shelf alternatives to xeno- and homografts. Biomaterials. 2012;33(18):4545–4554.
   PubMed Web of Science ®Google Scholar
• Driessen-Mol A, Emmert MY, Dijkman PE, et al. Transcatheter implantation of homologous “off-the-shelf” tissue-engineered heart valves with self-repair capacity: long-term functionality and rapid in vivo remodeling in sheep. J Am Coll Cardiol. 2014;63(13):1320–1329.
   PubMed Web of Science ®Google Scholar
• Schmitt B, Spriestersbach H, O H-Icí D, et al. Percutaneous pulmonary valve replacement using completely tissue-engineered off-the-shelf heart valves: six-month in vivo functionality and matrix remodelling in sheep. Euro Interv. 2016;12(1):62–70.
   Google Scholar
• Loerakker S, Ristori T, Baaijens FP. A computational analysis of cell-mediated compaction and collagen remodeling in tissue-engineered heart valves. J Mech Behav Biomed Mater. 2016;58:173–187.
   PubMed Web of Science ®Google Scholar
• Sanders B, Loerakker S, Fioretta ES, et al. Improved geometry of decellularized tissue engineered heart valves to prevent leaflet retraction. Ann Biomed Eng. 2016;44:1061–1071.
   PubMed Web of Science ®Google Scholar
• Emmert MY, Hoerstrup SP. Challenges in translating tissue engineered heart valves into clinical practice. Eur Heart J. 2017;38(9):619–621.
   PubMed Web of Science ®Google Scholar
• Emmert MY, Fioretta ES, Hoerstrup SP. Translational challenges in cardiovascular tissue engineering. J Cardiovasc Transl Res. 2017;10(2):139–149.
   PubMed Web of Science ®Google Scholar
• Emmert MY, Weber B, Behr L, et al. Transapical aortic implantation of autologous marrow stromal cell-based tissue-engineered heart valves: first experiences in the systemic circulation. JACC Cardiovasc Interv. 2011;4(7):822–823.
   PubMed Web of Science ®Google Scholar
• Emmert MY, Weber B, Behr L, et al. Transcatheter aortic valve implantation using anatomically oriented, marrow stromal cell-based, stented, tissue-engineered heart valves: technical considerations and implications for translational cell-based heart valve concepts. Eur J Cardiothorac Surg. 2014;45(1):61–68.
   PubMed Web of Science ®Google Scholar
• Emmert MY, Weber B, Wolint P, et al. Stem cell-based transcatheter aortic valve implantation: first experiences in a pre-clinical model. JACC Cardiovasc Interv. 2012;5(8):874–883.
   PubMed Web of Science ®Google Scholar
• Emmert MY, Hoerstrup SP. Next generation heart valve substitutes. Eur Heart J. 2017;38(9):617–618.
   PubMed Web of Science ®Google Scholar
• Emmert MY, Hoerstrup SP. Regenerative transcatheter valves. Eur Heart J. 2017;38(36):2710–2713.
   PubMed Web of Science ®Google Scholar
• Weber B, Dijkman PE, Scherman J, et al. Off-the-shelf human decellularized tissue-engineered heart valves in a non-human primate model. Biomaterials. 2013;34(30):7269–7280.
   PubMed Web of Science ®Google Scholar
• Weber B, Scherman J, Emmert MY, et al. Injectable living marrow stromal cell-based autologous tissue engineered heart valves: first experiences with a one-step intervention in primates. Eur Heart J. 2011;32(22):2830–2840.
   PubMed Web of Science ®Google Scholar
• Helder MRK, Stoyles NJ, Tefft BJ, et al. Xenoantigenicity of porcine decellularized valves. J Cardiothorac Surg. 2017;12(1):56.
   PubMedGoogle Scholar
• Tudorache I, Calistru A, Baraki H, et al. Orthotopic replacement of aortic heart valves with tissue-engineered grafts. Tissue Eng Part A. 2013;19(15–16):1686–1694.
   PubMed Web of Science ®Google Scholar
• Benichou G, Gonzalez B, Marino J, et al. Role of memory T cells in allograft rejection and tolerance. Front Immunol. 2017;8:170.
   PubMed Web of Science ®Google Scholar
• Reimer J, Syedain Z, Haynie B, et al. Implantation of a tissue-engineered tubular heart valve in growing lambs. Ann Biomed Eng. 2017;45(2):439–451.
   PubMed Web of Science ®Google Scholar
• Loerakker S, Argento G, Oomens CW, et al. Effects of valve geometry and tissue anisotropy on the radial stretch and coaptation area of tissue-engineered heart valves. J Biomech. 2013;46(11):1792–1800.
   PubMed Web of Science ®Google Scholar
• Dodge-Khatami A, Hallhagen S, Limacher K, et al. Minimally invasive insertion of an equine stented pulmonary valve with a built-in sinus portion in a sheep model. Catheter Cardiovasc Interv. 2012;79(4):654–658.
   PubMed Web of Science ®Google Scholar
• Syedain Z, Reimer J, Lahti M, et al. Tissue engineering of acellular vascular grafts capable of somatic growth in young lambs. Nat Commun. 2016;7:12951.
   PubMed Web of Science ®Google Scholar
• Hoerstrup SP, Cummings Mrcs I, Lachat M, et al. Functional growth in tissue-engineered living, vascular grafts: follow-up at 100 weeks in a large animal model. Circulation. 2006;114(1 Suppl):1159-–1166.
   Google Scholar
• Chinchoy E, Soule CL, Houlton AJ, et al. Isolated four-chamber working swine heart model. Ann Thorac Surg. 2000;70(5):1607–1614.
   PubMed Web of Science ®Google Scholar
• De Weger A, Van Tuijl S, Stijnen M, et al. Images in cardiovascular medicine. Direct endoscopic visual assessment of a transcatheter aortic valve implantation and performance in the Physioheart, an isolated working heart platform. Circulation. 2010;121(13):e261–262.
   PubMed Web of Science ®Google Scholar
• Rose M, Rahman O, Schnell S, et al. 4D flow MRI demonstrates changes in cardiovascular haemodynamics in complex congenital heart disease. Eur Heart J Cardiovasc Imaging. 2017;18(1):114.
   PubMed Web of Science ®Google Scholar
• Vy P, Auffret V, Badel P, et al. Review of patient-specific simulations of transcatheter aortic valve implantation. Int J Adv Eng Sci Appl Math. 2016;8(1):2–24.
   Web of Science ®Google Scholar
• Lawson JH, Glickman MH, Ilzecki M, et al. Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials. Lancet. 2016;387(10032):2026–2034.
   PubMed Web of Science ®Google Scholar